Multifunctional Nanodelivery Platform for Maximizing Nucleic Acids Combination Therapy.

TitleMultifunctional Nanodelivery Platform for Maximizing Nucleic Acids Combination Therapy.
Publication TypeJournal Article
Year of Publication2020
AuthorsLee SKoo, Law B, Tung C-H
JournalMethods Mol Biol
Volume2115
Pagination79-90
Date Published2020
ISSN1940-6029
KeywordsAnimals, Cell Line, Tumor, Drug Carriers, Drug Delivery Systems, Female, Gold, Humans, Hyaluronic Acid, Mice, Inbred BALB C, Mice, Nude, Nanoparticles, Neoplasms, Peptides, RNA, Small Interfering, RNAi Therapeutics, Static Electricity
Abstract

The silencing of an oncogene with a small interfering RNA (siRNA) is a promising way for cancer therapy. Its efficacy can be further enhanced by integrating with other therapeutics; however, transporting siRNA and other active ingredients to the same location at the same time is challenging. Here, we report a novel multifunctional nanodelivery platform by sequentially layering several functional ingredients, such as siRNAs, microRNAs, peptides, and targeting ligands, onto a core through charge-charge interaction. The prepared nanovectors effectively and programmably delivered multiple active components to maximize therapeutic combination with minimal off-targeting effects.

DOI10.1007/978-1-0716-0290-4_4
Alternate JournalMethods Mol Biol
PubMed ID32006395
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065